ORIGINAL ARTICLE
The diagnosis of cancer in thyroid fine needle aspiration biopsy. Surgery, repeat biopsy or specimen consultation?
Submission date: 2015-12-01
Acceptance date: 2016-01-03
Publication date: 2016-05-10
Pol J Pathol 2016;67(1):19-23
KEYWORDS
TOPICS
ABSTRACT
Fine needle aspiration biopsy (FNA) is the only diagnostic method that allows a preoperative diagnosis of thyroid carcinoma. An unequivocal diagnosis of a malignant change is achievable only in cases in which all cytological criteria of carcinoma are met. The aim of the study was to evaluate the necessity of repeat thyroid FNA in patients with papillary thyroid carcinoma verified on consultative examination (CE).
We analyzed cytology reports of thyroid FNA and CE that resulted in the diagnosis of papillary carcinoma. Evaluation of the correlation of the cytological diagnosis with the histopathology report was based on data obtained after the surgery.
Between 2010 and 2015 in the Institute of Oncology (IO) there were 184 cancers diagnosed on CE or in thyroid FNA performed primarily in IO. Additionally, 74 patients were subjected to repeat biopsy after confirmation of cancer in CE. Histopathological diagnosis of cancer was obtained in 62 (100%) cases that were doubly confirmed with cytological examination. The remaining 12 patients were operated on outside the institute. From 110 FNA primarily performed in the IO, histopathological verification was achievable in 92 cases, from which 92 (100%) provided a confirmation of cancer, and the remaining 18 patients were operated on outside the institute.
High (100%) specificity of cancer diagnosis in FNA established primarily and verified on CE (second independent assessment) indicates that repeat FNA in order to confirm the diagnosis is unnecessary.
We analyzed cytology reports of thyroid FNA and CE that resulted in the diagnosis of papillary carcinoma. Evaluation of the correlation of the cytological diagnosis with the histopathology report was based on data obtained after the surgery.
Between 2010 and 2015 in the Institute of Oncology (IO) there were 184 cancers diagnosed on CE or in thyroid FNA performed primarily in IO. Additionally, 74 patients were subjected to repeat biopsy after confirmation of cancer in CE. Histopathological diagnosis of cancer was obtained in 62 (100%) cases that were doubly confirmed with cytological examination. The remaining 12 patients were operated on outside the institute. From 110 FNA primarily performed in the IO, histopathological verification was achievable in 92 cases, from which 92 (100%) provided a confirmation of cancer, and the remaining 18 patients were operated on outside the institute.
High (100%) specificity of cancer diagnosis in FNA established primarily and verified on CE (second independent assessment) indicates that repeat FNA in order to confirm the diagnosis is unnecessary.
REFERENCES (42)
1.
Mazeh H, Beglaibter N, Prus D, et al. Cytohistologic correlation of thyroid nodules. Am J Surg 2007; 194: 161-163.
2.
Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol 2010; 38: 731-739.
3.
Theoharis C, Adeniran AJ, Roman S, et al. The impact of implementing The Bethesda System for reporting of thyroid FNA at an academic center. Diagn Cytopathol 2013; 41: 858-863.
4.
Mondal SK, Sinha S, Basak B, et al. The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up. J Cytol Indian Acad Cytol 2013; 30: 94-99.
5.
Cibas ES, Ali SZ. NCI Thyroid FNA State of the Science Conference The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 2009; 132: 658-665.
6.
Marchevsky AM, Walts AE, Bose S, et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn Cytopathol 2010; 38: 252-259.
7.
Dean DS, Gharib H. Fine-needle aspiration biopsy of the thyroid gland. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al. (eds.). Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.
8.
Jarząb B, Sporny S, Lange D, et al.; Polish Endocrinology Society, Polish Thyroid Society, Polish Pathologic Society et al. [Diagnosis and treatment of thyroid cancer – Polish guidelines]. Endokrynol Pol 2010; 61: 518-568.
9.
Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. CytoJournal 2008; 5: 6.
10.
Bugalho MJ, Santos JR, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 2005; 91: 56-60.
11.
Yang J, Schnadig V, Logrono R, et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 2007; 111: 306-315.
12.
McHenry CR, Walfish PG, Rosen IB. Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease. Am Surg 1993; 59: 415-419.
13.
Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med 1993; 13: 699-709.
14.
Damiani D, Suciu V, Vielh P. Cytopathology of follicular cell nodules. Endocr Pathol 2015; 26: 286-290.
15.
Mekel M, Gilshtein H, Al-Kurd A, et al. Negative fine-needle aspiration in patients with goiter: should we doubt it? World J Surg 2016; 40: 124-128.
16.
Lew JI, Snyder RA, Sanchez YM, et al. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg 2011; 213: 188-194.
17.
Strickland KC, Howitt BE, Marqusee E, et al. The impact of noninvasive follicular variant of papillary thyroid carcinoma on rates of malignancy for fine-needle aspiration diagnostic categories. Thyroid 2015; 25: 987-992.
18.
Mittendorf EA, Khiyami A, McHenry CR. When fine-needle aspiration biopsy cannot exclude papillary thyroid cancer: a therapeutic dilemma. Arch Surg 2006; 141: 961-966.
19.
Albuja-Cruz MB, Goldfarb M, Gondek SS, et al. Reliability of fine-needle aspiration for thyroid nodules greater than or equal to 4 cm. J Surg Res 2013; 181: 6-10.
20.
Kleiman DA, Beninato T, Soni A, et al. Does bethesda category predict aggressive features in malignant thyroid nodules? Ann Surg Oncol 2013; 20: 3484-3490.
21.
Srbova L, Gabalec F, Ryska A, et al. Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy? Cytopathology 2015; 26: 231-237.
22.
Chen JC, Pace SC, Chen BA, et al. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology. Surgery 2012; 152: 1037-1044.
23.
Broome JT, Cate F, Solorzano CC. Utilization and impact of repeat biopsy for follicular lesion/atypia of undetermined significance. World J Surg 2014; 38: 628-633.
24.
Ho AS, Sarti EE, Jain KS, et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 2014; 24: 832-839.
25.
Harvey AM, Mody DR, Amrikachi M. Thyroid fine-needle aspiration reporting rates and outcomes before and after Bethesda implementation within a combined academic and community hospital system. Arch Pathol Lab Med 2013; 137: 1664-1668.
26.
Shi Y, Ding X, Klein M, et al. Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category? Cancer 2009; 117: 298-304.
27.
Renshaw AA, Gould EW. Reducing indeterminate thyroid FNAs. Cancer Cytopathol 2015; 123: 237-243.
28.
Kholová I, Ludvíková M. Thyroid atypia of undetermined significance or follicular lesion of undetermined significance: an indispensable Bethesda 2010 diagnostic category or waste garbage? Acta Cytol 2014; 58: 319-329.
29.
Jang EK, Song DE, Gong G, et al. Positive cytology findings and a negative histological diagnosis of papillary thyroid carcinoma in the thyroid: is it a false-positive cytology or a disappearing tumor? Eur Thyroid J 2013; 2: 203-210.
30.
Polyzos SA, Anastasilakis AD. Clinical complications following thyroid fine-needle biopsy: a systematic review. Clin Endocrinol (Oxf) 2009; 71: 157-165.
31.
Hales MS, Hsu FS. Needle tract implantation of papillary carcinoma of the thyroid following aspiration biopsy. Acta Cytol 1990; 34: 801-804.
32.
Ito Y, Tomoda C, Uruno T, et al. Needle tract implantation of papillary thyroid carcinoma after fine-needle aspiration biopsy. World J Surg 2005; 29: 1544-1549.
33.
Ito Y, Asahi S, Matsuzuka F, et al. Needle tract implantation of follicular neoplasm after fine-needle aspiration biopsy: report of a case. Thyroid 2006; 16: 1059-1062.
34.
Uchida N, Suda T, Inoue T, et al. Needle track dissemination of follicular thyroid carcinoma following fine-needle aspiration biopsy: report of a case. Surg Today 2007; 37: 34-37.
35.
Xu B, Wang L, Tuttle RM, et al. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 278 cases. Hum Pathol 2015; 46: 1789-1798.
36.
Baloch ZW, LiVolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. Am J Clin Pathol 2006; 125 Suppl: S135-144.
37.
Faquin WC, Wong LQ, Afrogheh AH, et al. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol 2016; 124: 181-187.
38.
Rivera M, Tuttle RM, Patel S, et al. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 2009; 19: 119-127.
39.
Yang J, Gong Y, Yan S, et al. Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysis. Mol Clin Oncol 2015; 3: 753-764.
40.
Englum BR, Pura J, Reed SD, et al. A bedside risk calculator to preoperatively distinguish follicular thyroid carcinoma from follicular variant of papillary thyroid carcinoma. World J Surg 2015; 39: 2928-2934.
41.
Ganly I, Wang L, Tuttle RM, et al. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant. Hum Pathol 2015; 46: 657-664.
42.
Giorgadze TA, Scognamiglio T, Yang GCH. Fine-needle aspiration cytology of the solid variant of papillary thyroid carcinoma: a study of 13 cases with clinical, histologic, and ultrasound correlations. Cancer Cytopathol 2015; 123: 71-81.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
